{"transactions":[{"id":3848437,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-09T23:07:07.000Z","date":"2018-08-07","kind":"grant","acquired":true,"shares":415000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of August 7, 2018 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares underlying the options each monthly anniversary of the Vesting Commencement Date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the Vesting Commencement Date."}],"balance_after":415000,"derivative":{"exercise_price":3.07,"expiration_date":"2028-08-06","underlying":"Common Stock","underlying_shares":415000},"source":{"system":"sec-edgar","filing":"0001209191-18-046098","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919118046098/doc4.xml","form_type":"4"}},{"id":3998057,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-13T20:56:46.000Z","date":"2018-03-09","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of March 9, 2018 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares underlying the options each monthly anniversary of the vesting commencement date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the vesting commencement date."}],"balance_after":225000,"derivative":{"exercise_price":16.55,"expiration_date":"2028-03-08","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-18-019259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919118019259/doc4.xml","form_type":"4"}},{"id":4292726,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-05T23:00:11.000Z","date":"2017-06-05","kind":"exercise","acquired":false,"shares":3625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.6,"expiration_date":"2017-06-07","underlying":"Common Stock","underlying_shares":3625},"source":{"system":"sec-edgar","filing":"0001209191-17-037966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/doc4.xml","form_type":"4"}},{"id":4292725,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy(","published_at":"2017-06-05T23:00:11.000Z","date":"2017-06-02","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested."}],"balance_after":3625,"derivative":{"exercise_price":9.6,"expiration_date":"2017-06-07","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-037966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/doc4.xml","form_type":"4"}},{"id":4292724,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-05T23:00:11.000Z","date":"2017-06-01","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested."}],"balance_after":9625,"derivative":{"exercise_price":9.6,"expiration_date":"2017-06-07","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-037966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/doc4.xml","form_type":"4"}},{"id":4292723,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-05T23:00:11.000Z","date":"2017-06-05","kind":"sale","acquired":false,"shares":3625,"price":13.1575,"value":47695.9375,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.04 to $13.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set in this footnote."}],"balance_after":71530,"source":{"system":"sec-edgar","filing":"0001209191-17-037966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/doc4.xml","form_type":"4"}},{"id":4292722,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-05T23:00:11.000Z","date":"2017-06-05","kind":"exercise","acquired":true,"shares":3625,"price":9.6,"value":34800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise of options reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2017."}],"balance_after":75155,"source":{"system":"sec-edgar","filing":"0001209191-17-037966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/doc4.xml","form_type":"4"}},{"id":4292721,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-05T23:00:11.000Z","date":"2017-06-02","kind":"sale","acquired":false,"shares":6000,"price":13.5933,"value":81559.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.45 to $13.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set in this footnote."}],"balance_after":71530,"source":{"system":"sec-edgar","filing":"0001209191-17-037966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/doc4.xml","form_type":"4"}},{"id":4292720,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-05T23:00:11.000Z","date":"2017-06-02","kind":"exercise","acquired":true,"shares":6000,"price":9.6,"value":57600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise of options reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2017."}],"balance_after":77530,"source":{"system":"sec-edgar","filing":"0001209191-17-037966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/doc4.xml","form_type":"4"}},{"id":4292719,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-05T23:00:11.000Z","date":"2017-06-01","kind":"sale","acquired":false,"shares":6000,"price":12.998,"value":77988.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $12.82 to $13.20, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set in this footnote."}],"balance_after":71530,"source":{"system":"sec-edgar","filing":"0001209191-17-037966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/doc4.xml","form_type":"4"}},{"id":4292718,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-05T23:00:11.000Z","date":"2017-06-01","kind":"exercise","acquired":true,"shares":6000,"price":9.6,"value":57600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise of options reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2017."}],"balance_after":77530,"source":{"system":"sec-edgar","filing":"0001209191-17-037966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117037966/doc4.xml","form_type":"4"}},{"id":4390619,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":164411,"kind":"person","name":"Main David","position":1,"cik":"0001599941","reported_name":"Main David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-11T02:16:00.000Z","date":"2017-03-08","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of March 8, 2017 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares underlying the options each monthly anniversary of the vesting commencement date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the vesting commencement date."}],"balance_after":185000,"derivative":{"exercise_price":17.35,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001209191-17-020011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000120919117020011/doc4.xml","form_type":"4"}}]}